menu
    • menu

    Company profile for Chimerix

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Chimerix, we’re on a mission to discover and develop much-needed medicines that protect immunocompromised patients from potentially devastating viral infections. For people with weakened immune systems and patients undergoing bone marrow transplants, common viruses can quickly become life-threatening.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ChimerixUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham, NC 27713
    Telephone
    Telephone
    1-919-806-1074
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.chimerix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/chimerix-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/chimerix

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immix Bio Appoints Chief Commercial Officer For NXC-201 Launch
    Immix Bio Appoints Chief Commercial Officer For NXC-201 Launch

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186298/0/en/Immix-Biopharma-Appoints-Chief-Commercial-Officer-to-Drive-NXC-201-Launch.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Chimerix’s Modeyso Receives Approval in US
    Chimerix’s Modeyso Receives Approval in US

    06 Aug 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219876

    FDA
    06 Aug 2025
    Share Share
    Jazz Pharmaceuticals Completes Acquisition of Chimerix
    Jazz Pharmaceuticals Completes Acquisition of Chimerix

    21 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-completes-acquisition-of-chimerix-302433612.html

    PR NEWSWIRE
    21 Apr 2025
    Share Share
    Chimerix Reports Q4 2024 Financial Results
    Chimerix Reports Q4 2024 Financial Results

    21 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/21/3046953/25619/en/Chimerix-Reports-Fourth-Quarter-and-Year-End-2024-Financial-Results.html

    GLOBENEWSWIRE
    21 Mar 2025
    Share Share
    Chimerix had 8 suitors: Why Jazz won out
    Chimerix had 8 suitors: Why Jazz won out

    21 Mar 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/chimerix-engaged-7-other-biopharmas-choosing-jazzs-935m-deal-heres-why-jazz-won

    FIERCE BIOTECH
    21 Mar 2025
    Share Share
    Chimerix Reports Inducement Grants Under Nasdaq Rule 5635(c)(4)
    Chimerix Reports Inducement Grants Under Nasdaq Rule 5635(c)(4)

    07 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/07/3039230/25619/en/Chimerix-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    07 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search